Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study

Chest

Volumn 109, Issue 2, 1996, Pages 438-445

  Murray, Robert P ^a   Bailey, William C ^b   Daniels, Kathleen ^c   Bjornson, Wendy M ^d   Kurnow, Karole ^c   Connett, John E ^c,g   Nides, Mitchell A ^e   Kiley, James P ^f  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g Lung Hlth Study Coordinating Center   (United States)

Author keywords

cardiovascular illness; clinical trial; nicotine gum; side effects; smoking cessation

Indexed keywords

NICOTINE GUM;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MONITORING; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; INDIGESTION; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION;

EID: 0030067550     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.109.2.438     Document Type: Article

References (13)

1. Lam W, Sze PC, Sacks HS, et al. Meta-analysis of randomized controlled trials of nicotine chewing-gum. Lancet 1987; 2:27-30
2. Christen AG, McDonald JL, Olson BL, et al. Efficacy of nicotine chewing gum in facilitating smoking cessation. J Am Dent Assoc 1984; 108:594-97
3. Jarvis MJ, Raw M, Russell MAH, et al. Randomized controlled trial of nicotine chewing gum. BMJ 1982; 285:537-40
4. Hughes JR. Risk-benefit assessment of nicotine preparations in smoking cessation. Drug Saf 1993; 8:49-56
5. Connett JE, Kusek JW, Bailey WC, et al. Design of the Lung Health Study: a randomized clinical trial of early intervention for chronic obstructive pulmonary disease. Control Clin Trials 1993; 14:3S-19S
6. 1: the Lung Health Study. JAMA 1994; 272:1497-1505
7. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123:659-64
8. Durkin DA, Kjelsberg MO, Buist S, et al. Recruitment of participants in the Lung Health Study: I. Description of methods. Control Clin Trials 1993; 14:20S-37S
9. O'Hara P, Grill J, Rigdon MA, et al. Design and results of the initial intervention program for the Lung Health Study. Prev Med 1993; 22:304-15
10. Murray RP, Connett JE, Lauger GG, et al. Error in smoking measures: effects of intervention on relationships of cotinine and carbon monoxide to self-reported smoking. Am J Public Health 1993; 83:1251-57
11. SAS Institute Inc. SAS technical report P-217: the PHREG procedure: version 6. Cary, NC: SAS Institute, 1991;1-27
12. Russell MAH. Nicotine replacement: the role of blood nicotine levels, their rate of change, and nicotine tolerance. In: Pomerleau OF, Pomerleau CS, eds. Nicotine replacement: a critical evaluation. New York: Alan R Liss, 1988; 63-94
13. Tønnesen P. Dose and nicotine dependence as determinants of nicotine gum efficacy. In: Pomerleau OF, Pomerleau CS, eds. Nicotine replacement: a critical evaluation. New York: Alan R Liss, 1988; 129-144